Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may forecast burn survival odds

NCT ID NCT07761845

Knowledge-focused Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Aug 19, 2026 · Updated 3 times

Summary

This study tests whether a simple blood test, taken within 24 hours of a severe burn injury, can help predict a patient's chances of surviving the next 30 days. The test measures the ratio of red cell distribution width to albumin levels, which may reflect inflammation and nutritional status. Researchers will follow 30 adult burn patients in the ICU to see if this ratio correlates with mortality and length of stay, potentially offering a quick and easy tool for risk assessment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Red cell distribution width/albumin ratio (RAR) measured from a blood test
What this could lead to
If proven reliable, this simple blood test could help doctors quickly identify burn patients at higher risk of death, guiding more intensive care and potentially saving lives.
What could go wrong
This is a small, early study (30 patients) that only looks at whether the test predicts outcomes, not whether it improves them. The results may not apply to all burn patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients presenting with acute thermal injuries will be screened based on inclusion/exclusion criteria. After consent, Patients' characteristics (age, sex, weight), clinical parameters (Total burn surface area, Abbreviated burn severity index), and comorbidities will be recorded.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 18 years. * Both sexes. * Patients with burn injuries (%TBSA \>20%). * Availability of complete laboratory data (RDW, albumin) on admission. * Admission to ICU within 24 hours of burn injury. Exclusion Criteria: * Age \<18 years. * Patients with chronic hematologic disease. * Pre-existing liver disease. * Nephrotic syndrome. * patients on chemotherapy. * Patients with incomplete or missing lab records. * Pregnant females. * Patient or guardian refusal.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Burn injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

burn

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Burn injuries Mortality prediction of patients with burn injuries

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ain shams university

    RECRUITING

    Cairo, Cairo Governorate, 11111, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.